r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

AO

Adeoye Y. Olukotun

Insider · Director · ARWR

Adeoye Y. Olukotun files insider transactions with the SEC as a director of Arrowhead Pharmaceuticals (ARWR). We hold 1 disclosed purchase or sale filed since 7 August 2006, 1 of them in the last 90 days.

  • Files forARWR
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure20 August 2026

Positions held

7 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 1 January 2021 — 18 August 2026Director · Arrowhead Pharmaceuticals (ARWR)19 Form 4 lines · source: SEC Form 4
  • Filed 5 September 2018 — 12 May 2026Director · Tonix Pharmaceuticals Holding (TNXP)11 Form 4 lines · source: SEC Form 4
  • Filed 31 July 2013 — 29 May 2014Director · diaDexus (DDXS)3 Form 4 lines · source: SEC Form 4
  • Filed 12 May 2010 — 12 March 2013Director · Bioclinica (BIOC)4 Form 4 lines · source: SEC Form 4
  • Filed 3 August 2006 — 27 October 2011Director · Icagen (ICGN)17 Form 4 lines · source: SEC Form 4
  • Filed 25 August 2008 — 8 July 2009Director · Bio Imaging Technologies (BITI)2 Form 4 lines · source: SEC Form 4
  • Filed 5 June 2007 — 17 December 2007Chief Medical Officer · VIA Pharmaceuticals (VIAP)4 Form 4 lines · source: SEC Form 4

Everything they disclosed

60 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.